From Deseret News archives:

Y. chemists discover way to help drug production

Team finds cheaper, more efficient way to create synthetic molecule

Published: Monday, Oct. 17, 2005 12:46 a.m. MDT
 |  E-MAIL | PRINT | FONT + - 
PROVO — A group of Brigham Young University chemists has developed a cheaper, more efficient way of producing a synthetic molecule that is widely used in modern prescription drugs.

The team was led by BYU chemistry professor Merritt Andrus, who worked with graduate student Erik Hicken and undergraduate students Jeff Stevens and Karl Bedke.

Their discovery could have broad implications in the discovery, production, and possibly the cost of many forthcoming drugs.

Many next-generation prescription drugs, currently in the trial phase of development, rely on chiral molecules, which allow a drug to specifically target infected protein chains in the body and directly treat them.

"In order to intervene and treat a virus, you need to identify a specific protein that is not functioning properly and bind selectively to it," Andrus said. "Chiral molecules are being used more and more, because those protein targets (in the body) are also chiral."

Chiral molecules are asymmetrical and can occur in a "left-handed" or "right-handed" form, depending on which side of the molecule is open for binding to another molecule.

Story continues below
For medicinal purposes, only the left-handed type is useful. Under previous methods of producing chiral molecules, however, both types were produced in equal amounts and half of every batch of chiral molecules went to waste.

But the new process discovered by the BYU team uses an inexpensive protein found in plants, quinine, as a catalyst to force the chiral molecules to all form with the same orientation. Quinine itself is a protein molecule that is always "one-handed."

"Our method improves the efficiency of making this product," Andrus said. "Pharmaceutical companies can more easily make chiral molecules in this class now . . . to discover new drugs, screen new drugs, and also in production."

Andrus said he doesn't know what impact the new process would have on prescription drug prices but said it could potentially drive costs down.

"We didn't do a cost analysis, but this way is more efficient," he said. "There's fewer steps, and you don't waste half the product."

The results of the BYU experiment, which was conducted on a specific type of type 2 diabetes drug that will soon be on the market, appear in the latest issue of the Journal of Organic Chemistry.

The team is already working to expand the applications to other types of diabetes drugs.

"We're working on an improved method; applying this process to other drugs with similar specific needs," said Erik Hicken, a graduate student who worked closely with Andrus on the project. "There are three or four other diabetes drugs in trials with similar needs."

Comments

You can be the first to comment on this story.

Image
Mark A. Philbrick, BYU

BYU chemistry professor Merritt Andrus, standing, and undergraduate student Karl Bedke worked on the project.

previousnext

Latest comments

Yes, that is the game I'm refering to, the one that more people in this state...

I have known Mayor Wood since we were little girls attending Madison...

Real Champions

Great game!!!! I agree, ESPN just hates any team from Utah. I got so sick of...

Where are the soccer players comments....this happens all the time and is...

Did you forget the Utah Stars in 1971? They were the first.

How a seer stone helped in translation

I dont and I doubt that anyone else does either. Thats why its called FAITH....

Nobody is stopping the religious lunatics from speaking out; however, we will...

Big congratulations to coach McBride and his Wildcats. Hope they win it all.

Real Champions

Oh, I get it, kids play soccer and get a treat afterwards...so, soccer must...

The hate expressed here reminds me of why I like Reagan

Advertisements